Full-Time

Director – Contracts Attorney

Posted on 9/14/2024

Lyell Immunopharma

Lyell Immunopharma

201-500 employees

Develops advanced cell therapies for cancer

Biotechnology
Healthcare

Compensation Overview

$220k - $255kAnnually

+ Annual Bonus + Equity Incentive Plan

Senior, Expert

San Bruno, CA, USA

Category
Legal
Legal & Compliance
Requirements
  • JD from an accredited Law School with a minimum of 15 years experience
  • Minimum ten years of contract management-level experience within a contract function of a life science/biotech company.
  • Significant demonstrated experience with an electronic document management system or contract management system.
  • Proven experience negotiating all types of vendor-based and other company agreements.
  • Proficient in Microsoft Office or similar software programs and computer applications.
  • Self-motivated team player with solid communication and leadership skills.
  • Able to make decisions quickly and effectively.
  • Detail-oriented and organized.
  • Able to prioritize multiple responsibilities under business objectives.
  • Able to anticipate/spot legal and business issues in contracts.
  • Able to work cross-functionally, taking the initiative to ensure corporate policies are followed.
  • Able and willing to take on additional roles and functions to support the law department and company operations.
  • High personal and business ethics.
  • Understands and supports a 'patient-first' mentality.
Responsibilities
  • Lead the drafting, review, interpretation, negotiation, and execution of day-to-day, high-risk vendor-based agreements such as master services agreements, supply/purchase agreements, technology transfer agreements, and material transfer agreements while appropriately engaging the Legal team or outside counsel for complicated agreements, terms, or negotiations.
  • Serve as liaison between outside counsel and business owners for high-risk/high-value transactions and escalate appropriate issues for senior-level decision-making.
  • Partner with business owners to obtain and incorporate business input on business issues raised by the contract, advising business owners of potential risks and discussing mitigation options and otherwise drive contract negotiations to completion.
  • Training Lyell employees on the Standard Operating Procedure for the review of contracts and related processes.
  • Oversee junior attorneys, paralegals, and/or consultants in the drafting, review, interpretation, negotiation, and execution of routine agreements, such as confidentiality, material transfer, consulting, services, and clinical trial-related agreements.
  • Develop and maintain an alternative language library to facilitate quick turnaround of contracts.
  • Assist the Legal team with complicated or strategic transactions, corporate compliance, or other areas of law where legal support is required.
  • Lead the continuous improvement of the Legal function’s operations through problem-solving, strategic planning, project management, process and systems improvement, and financial/budget management.

Lyell Immunopharma develops advanced cell therapies aimed at treating solid tumors, which are cancerous tissue masses. The company focuses on enhancing T cells, a type of immune cell, to effectively target and eliminate cancer cells. Their approach includes genetic and epigenetic reprogramming of T cells to address challenges like T cell exhaustion and to ensure T cells can persist in the body. Unlike many competitors, Lyell is dedicated to creating curative treatments specifically for solid tumors, utilizing a diverse product pipeline that explores various treatment methods. The goal is to push the limits of current cancer therapies and provide effective solutions where traditional treatments have not succeeded.

Company Stage

IPO

Total Funding

$479.6M

Headquarters

San Francisco, California

Founded

2018

Growth & Insights
Headcount

6 month growth

0%

1 year growth

-17%

2 year growth

-13%
Simplify Jobs

Simplify's Take

What believers are saying

  • Acquisition of ImmPACT Bio enhances Lyell's T-cell therapy capabilities.
  • Experienced leadership team strengthens strategic direction and operational efficiency.
  • New manufacturing facility in Bothell boosts production capacity and technology scaling.

What critics are saying

  • Increased competition in CAR T-cell therapies may impact market share.
  • Delays in clinical data results could affect investor confidence.
  • Regulatory scrutiny on reprogramming technologies may delay product approvals.

What makes Lyell Immunopharma unique

  • Lyell focuses on T cell reprogramming to treat solid tumors effectively.
  • Their Gen-R and Epi-R platforms address T cell exhaustion and stemness loss.
  • Lyell's dual-targeting CAR T-cell therapies offer innovative cancer treatment solutions.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE